Carla Villalba

As we head into 2024, the corporate landscape is buzzing with the emergence of potential billion-dollar companies. Forbes, in its annual effort to spotlight future unicorns, has already identified more than a hundred startups poised to reshape industries. This year’s lineup includes a wide range of innovators, from aerospace manufacturers to AI-driven tech companies, each bringing something unique to the table. A Journey of Resilience and Innovation Among the most inspiring stories is that of an entrepreneur who overcame anorexia to secure a whopping $110 million in funding for online treatment innovations. This remarkable journey not only highlights personal resilience,…

This year’s Bastille Day festivities in New York had a different feel, noted Violaine Huisman, artistic director of the prestigious Crossing the Line festival. Held at L’Alliance, the French cultural center in Midtown, the celebration came just a week after an unexpected snap election that left both President Emmanuel Macron and the nation reeling. Huisman, recently returned from France, noted the unique expression of this year’s festival attendees as they marched with empty signs. The gesture, he explained, was a tribute to an iconic 1960s demonstration conceptualized by choreographer Anna Halprin in the heat of the civil rights and anti-war…

In the tranquil confines of the Morgan Library & Museum, a fascinating discovery took place in 2019. Associate Curator Robinson McClellan delved into Robert Owen Lehman’s collection of music manuscripts, revealing a treasure trove tied to the iconic Ballets Russes. Founded by Sergei Diaghilev in 1909 in Paris, the Ballets Russes are renowned for their sweeping influence on 20th-century performing arts. The collection, enriched by scores by luminaries such as Stravinsky, Debussy and Ravel, offers a rare glimpse into the creative processes behind the Ballets Russes' groundbreaking productions. These documents, heavily marked with notes and revisions, expose the dynamic evolution…

In the dynamic world of communication, America is experiencing a boom of new media that challenge the status quo and provide unprecedented news value. These innovative players in the media landscape, far from being mere add-ons, are emerging as reliable and fresh alternatives, captivating diverse audiences and transforming the way we consume news and information. What makes these new media so special? Diversity and plurality of voices: Unlike traditional media, often concentrated in large conglomerates, new media give voice to a wide range of perspectives and narratives, from indigenous communities to underrepresented minorities. This enriches public debate and promotes a…

Peregrine Technologies, a pioneering startup founded by former Palantir executives, is poised to revolutionize the field of law enforcement. By harnessing the power of advanced technology, Peregrine aims to equip police departments with the tools they need to improve public safety while upholding civil liberties. At the heart of Peregrine’s innovation is its cutting-edge platform, which seamlessly integrates multiple data sources into a unified interface. This powerful tool enables law enforcement to access critical information quickly and efficiently, allowing them to make informed decisions and respond to incidents more effectively. Unlike traditional surveillance systems, Peregrine’s technology prioritizes both efficiency and…

In a recent long-term research study published Tuesday, Eli Lilly reported that its popular weight-management drug significantly reduced the incidence of type 2 diabetes by 94 percent among overweight or obese adults who had prediabetic symptoms, compared to a control group that received a placebo. The late-stage study explored the effects of tirzepatide, the active compound in both Eli Lilly’s Zepbound weight-loss shot and the diabetes treatment Mounjaro. Over about three years, participants who received the highest weekly dose of tirzepatide experienced an average reduction in body weight of 22.9 percent, while those who took a placebo saw only a…